| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.EJSO.2007.07.007 |
| P698 | PubMed publication ID | 17764887 |
| P2093 | author name string | J N Vauthey | |
| G Morris-Stiff | |||
| Y-M Tan | |||
| P433 | issue | 6 | |
| P921 | main subject | irinotecan | Q412197 |
| oxaliplatin | Q422327 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | 609-614 | |
| P577 | publication date | 2007-08-30 | |
| P1433 | published in | European Journal of Surgical Oncology | Q2345728 |
| P1476 | title | Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases | |
| P478 | volume | 34 |
| Q36498487 | A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery |
| Q33715042 | A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment |
| Q36953786 | A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases |
| Q53397241 | Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. |
| Q26740331 | Acute renal injury after partial hepatectomy |
| Q37821285 | Advances in therapeutics for liver metastasis from colorectal cancer |
| Q38230654 | Advances in understanding of colorectal liver metastasis and implications for the clinic |
| Q43248217 | An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate. |
| Q50027558 | Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy |
| Q36964263 | Capecitabine-related liver lesions: sinusoidal dilatation mimicking liver metastasis |
| Q36343394 | Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury. |
| Q38024277 | Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis |
| Q51004122 | Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome. |
| Q36063283 | Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity |
| Q85050931 | Dietary glycine protects from chemotherapy-induced hepatotoxicity |
| Q50240420 | Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test |
| Q44531757 | Evaluation of neoadjuvant chemotherapy effects on liver parenchyma in resected pediatric malignancies. |
| Q46580016 | First-line combination treatment of colorectal cancer with hepatic metastases: choosing a targeted agent |
| Q33561369 | Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates |
| Q36946329 | Hepatic colorectal metastases involving infra-hepatic inferior vena cava in high risk patients for extended resection: an alternative method for achieving radical resection in patient with borderline liver remnant |
| Q51804140 | Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. |
| Q38037067 | Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients |
| Q37067634 | Liver injury induced by anticancer chemotherapy and radiation therapy |
| Q38008289 | Liver metastases from colorectal cancer: technique of liver resection |
| Q37904901 | Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review |
| Q34602250 | National trends in discharge disposition after hepatic resection for malignancy |
| Q43092644 | Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes |
| Q50923685 | Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases. |
| Q35755386 | Pancreatic cancer and FOLFIRINOX: a new era and new questions |
| Q37326848 | Part I: Liver function in oncology: biochemistry and beyond |
| Q44692003 | Patient Selection and Activity Planning Guide for Selective Internal Radiotherapy With Yttrium-90 Resin Microspheres |
| Q51777376 | Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy. |
| Q53093475 | Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy. |
| Q37711334 | Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. |
| Q37037106 | Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement |
| Q38002990 | The developing clinical problem of chemotherapy-induced hepatic injury |
| Q38528849 | Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? |
| Q37165886 | Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer |
| Q84090284 | [Key events from the 4th French-speaking congress on digestive and hepatobiliary surgery: synthesis of the oral communications and report of symposium. December 4-6 2008, Paris] |
Search more.